U.S. markets closed
  • S&P Futures

    4,232.25
    +7.00 (+0.17%)
     
  • Dow Futures

    34,752.00
    +66.00 (+0.19%)
     
  • Nasdaq Futures

    13,731.75
    +22.00 (+0.16%)
     
  • Russell 2000 Futures

    2,272.40
    +4.50 (+0.20%)
     
  • Crude Oil

    65.52
    +0.62 (+0.96%)
     
  • Gold

    1,833.90
    +2.60 (+0.14%)
     
  • Silver

    27.71
    +0.23 (+0.85%)
     
  • EUR/USD

    1.2170
    +0.0001 (+0.01%)
     
  • 10-Yr Bond

    1.5770
    +0.0160 (+1.02%)
     
  • Vix

    16.69
    -1.70 (-9.24%)
     
  • GBP/USD

    1.4038
    +0.0049 (+0.35%)
     
  • USD/JPY

    108.7100
    +0.1280 (+0.12%)
     
  • BTC-USD

    58,157.80
    -649.82 (-1.11%)
     
  • CMC Crypto 200

    1,532.67
    +96.89 (+6.75%)
     
  • FTSE 100

    7,129.71
    +53.54 (+0.76%)
     
  • Nikkei 225

    29,357.82
    0.00 (0.00%)
     

Ovid Therapeutics (OVID) Jumps: Stock Rises 12.4%

  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.
Zacks Equity Research
·2 min read
  • Oops!
    Something went wrong.
    Please try again later.
  • Oops!
    Something went wrong.
    Please try again later.

Ovid Therapeutics Inc. OVID was a big mover last session, as the company saw its shares rise more than 12% on the day. The move came on solid volume too with far more shares changing hands than in a normal session. This breaks the recent trend of the company, as the stock is now trading above the volatile price range of $4.83 to $7.40 in the past one-month time frame.

The company has seen one negative estimate revision in the past two months, while its Zacks Consensus Estimate for the current quarter has also moved lower in the same time frame, suggesting there may be trouble down the road. So make sure to keep an eye on this stock going forward, to see if this recent move higher can last.

Ovid Therapeutics currently has a Zacks Rank #3 (Hold) while its Earnings ESP is 0.00%.

Ovid Therapeutics Inc. Price

OVID THERAPEUTC Price
OVID THERAPEUTC Price

Ovid Therapeutics Inc. price | Ovid Therapeutics Inc. Quote

A better-ranked stock in the Medical – Biomedical and Genetics industry is Gamida Cell Ltd. GMDA, which currently carries a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.

5 Stocks Set to Double

Each was hand-picked by a Zacks expert as the #1 favorite stock to gain +100% or more in 2020. Each comes from a different sector and has unique qualities and catalysts that could fuel exceptional growth.

Most of the stocks in this report are flying under Wall Street radar, which provides a great opportunity to get in on the ground floor.

Today, See These 5 Potential Home Runs >>


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
OVID THERAPEUTC (OVID) : Free Stock Analysis Report
 
Gamida Cell Ltd. (GMDA) : Free Stock Analysis Report
 
To read this article on Zacks.com click here.
 
Zacks Investment Research